Showing results (1241-1250 of 2,873) with videos related to

Sort By:
Pageof 288
Biological Psychiatry|November 6, 2007
White matter lesions as a predictor of depression in the elderly: the 3C-Dijon studyOphélia Godin, Carole Dufouil, Pauline Maillard, et al.
Analytical Chemistry|March 30, 2021
Exploring Complex Mixtures by Cyclic Ion Mobility High-Resolution Mass Spectrometry: Application Toward PetroleumChristopher P Rüger, Johann Le Maître, Julien Maillard, et al.
Bioengineering (Basel, Switzerland)|April 28, 2023
The Effectiveness of Calcium Phosphates in the Treatment of Dentinal Hypersensitivity: A Systematic ReviewMélanie Maillard, Octave Nadile Bandiaky, Suzanne Maunoury, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2002
In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonistMarc P Maillard, Christine Perregaux, Catherine Centeno, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 5, 2002
[Neonatal renal vein thrombosis in a heterozygous carrier of both factor V Leiden and prothrombin mutations]N Leret, A Cortey, C Maillard, et al.
Kidney International|May 31, 2001
Compensatory up-regulation of angiotensin II subtype 1 receptors in alpha ENaC knockout heterozygous miceQ Wang, E Hummler, M Maillard, et al.
Annales De Dermatologie Et De Venereologie|December 28, 2019
[Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab]L Delaitre, J Martins-Héricher, E Truchot, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 20, 2005
[Postoperative radiotherapy in N0 laryngeal cancer]S Maillard, N Jovenin, A Cauchois, et al.
The Journal of Experimental Medicine|November 26, 2009
GATA-3 is required for early T lineage progenitor developmentTomonori Hosoya, Takashi Kuroha, Takashi Moriguchi, et al.
International Clinical Psychopharmacology|April 1, 1990
Steady state pharmacokinetics of zopiclone during multiple oral dosing (7.5 mg nocte) in patients with severe chronic renal failureB Viron, M De Meyer, A Le Liboux, et al.
Pageof 288